Publicaciones en colaboración con investigadores/as de Charité (35)

2024

  1. Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries

    European Psychiatry, Vol. 67, Núm. 1

  2. Identification and treatment of individuals with childhood-onset and early-onset schizophrenia

    European Neuropsychopharmacology, Vol. 82, pp. 57-71

  3. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

  4. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis

    The Lancet Psychiatry, Vol. 11, Núm. 1, pp. 36-46

  5. Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset Psychosis

    Journal of the American Academy of Child and Adolescent Psychiatry

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Country-level gender inequality is associated with structural differences in the brains of women and men

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 20

  3. Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery

    BMC Psychiatry, Vol. 23, Núm. 1

  4. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence

    Molecular Psychiatry, Vol. 28, Núm. 1, pp. 354-368

  5. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis

    British Journal of Psychiatry, Vol. 31, Núm. 2

  6. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149

  7. Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults

    Journal of Affective Disorders, Vol. 326, pp. 249-261

2022

  1. Ethical considerations for precision psychiatry: A roadmap for research and clinical practice

    European Neuropsychopharmacology, Vol. 63, pp. 17-34

  2. Genetic variants associated with longitudinal changes in brain structure across the lifespan

    Nature neuroscience, Vol. 25, Núm. 4, pp. 421-432

  3. Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review

    Molecular Psychiatry, Vol. 27, Núm. 8, pp. 3510-3519

  4. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  5. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

    Journal of Affective Disorders, Vol. 299, pp. 367-376

  6. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic

    Journal of Affective Disorders, Vol. 299, pp. 393-407

  7. The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis

    The Lancet Psychiatry, Vol. 9, Núm. 7, pp. 565-573

  8. The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations

    European Neuropsychopharmacology, Vol. 59, pp. 45-55